Patent · US Active

Crystal form of hepatitis B surface antigen inhibitor

US12103936B2 · kind B2 · utility

0Cited by
1References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 22, 2019
Grant dateOct 1, 2024
Priority date
Expiry dateNov 3, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention discloses a crystal form of a hepatitis B surface antigen inhibitor and a preparation method therefor, and also comprises the use of the crystal form in preparing the hepatitis B surface antigen inhibitor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.